Targeting Stromal-Cancer Cell Crosstalk Networks in Ovarian Cancer Treatment
Ovarian cancer is a histologically, clinically, and molecularly diverse disease with a five-year survival rate of less than 30%. It has been estimated that approximately 21,980 new cases of epithelial ovarian cancer will be diagnosed and 14,270 deaths will occur in the United States in 2015, making...
Main Authors: | Tsz-Lun Yeung, Cecilia S. Leung, Fuhai Li, Stephen S.T. Wong, Samuel C. Mok |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-01-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | http://www.mdpi.com/2218-273X/6/1/3 |
Similar Items
-
The Role of Cancer-Associated Fibroblasts in Ovarian Cancer
by: Mo Zhang, et al.
Published: (2022-05-01) -
In-Depth Characterization of Stromal Cells within the Tumor Microenvironment Yields Novel Therapeutic Targets
by: Sebastian G. Walter, et al.
Published: (2021-03-01) -
Prognostic Value of Tumor-microenvironment-associated Genes in Ovarian Cancer
by: Shimei Li, et al.
Published: (2023-11-01) -
c-MYC mediates the crosstalk between breast cancer cells and tumor microenvironment
by: Fang-yan Gao, et al.
Published: (2023-01-01) -
Clinical and histological criteria for sex cord ovarian stromal tumors
by: A. М. Beishembaev, et al.
Published: (2020-09-01)